AF
Andrew Fein HC Wainwright & Co. Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
United Therapeutics
UTHR
$17.8B
| $394.62 | $500 |
27%
upside
| Buy |
5 Sep ‘25
3 days ago |
|
2
Biogen
BIIB
$20.7B
| $141.35 | $194 |
37%
upside
| Buy |
1 Aug ‘25
1 month ago |
|
3
Fulcrum Therapeutics
FULC
$393M
| $7.27 | $12 |
65%
upside
| Buy |
29 Jul ‘25
1 month ago |
|
4
KalVista Pharmaceuticals
KALV
$803M
| $15.96 | $27 |
69%
upside
| Buy |
11 Jul ‘25
1 month ago |
|
5
Candel Therapeutics
CADL
$280M
| $5.10 | $23 |
351%
upside
| Buy |
30 Jun ‘25
2 months ago |
|
6
Kymera Therapeutics
KYMR
$3.09B
| $43.26 | $60 |
39%
upside
| Buy |
26 Jun ‘25
2 months ago |
|
7
Acadia Pharmaceuticals
ACAD
$4.28B
| $25.39 | $32 |
26%
upside
| Buy |
26 Jun ‘25
2 months ago |
|
8
Vertex Pharmaceuticals
VRTX
$101B
| $395.25 | $550 |
39%
upside
| Buy |
23 Jun ‘25
2 months ago |
|
9
Insmed
INSM
$31B
| $146.68 | $120 |
18%
downside
| Buy |
11 Jun ‘25
2 months ago |
|
10
PepGen
PEPG
$48.9M
| $1.49 | $8 |
437%
upside
| Buy |
29 May ‘25
3 months ago |
|
11
Savara
SVRA
$665M
| $3.85 | $2 |
48%
downside
| Neutral |
29 May ‘25
3 months ago |
|
12
Liquidia Corp
LQDA
$2.41B
| $27.98 | $35 |
25%
upside
| Buy |
28 May ‘25
3 months ago |
|
13
Prothena Corp
PRTA
$457M
| $8.49 | $14 |
65%
upside
| Buy |
27 May ‘25
3 months ago |
|
14
Stoke Therapeutics
STOK
$1.2B
| $21.99 | $35 |
59%
upside
| Buy |
14 May ‘25
3 months ago |
|
15
Annexon
ANNX
$243M
| $2.21 | $14 |
533%
upside
| Buy |
14 May ‘25
3 months ago |
|
16
Structure Therapeutics
GPCR
$1.2B
| $20.86 | $75 |
260%
upside
| Buy |
12 May ‘25
3 months ago |
|
17
Avidity Biosciences
RNA
$6.18B
| $48.05 | $68 |
42%
upside
| Buy |
12 May ‘25
3 months ago |
|
18
Alector
ALEC
$279M
| $2.76 | $10 |
262%
upside
| Buy |
9 May ‘25
4 months ago |
|
19
Dyne Therapeutics
DYN
$1.89B
| $13.30 | $38 |
186%
upside
| Buy |
9 May ‘25
4 months ago |
|
20
Amylyx Pharmaceuticals
AMLX
$931M
| $10.44 | $16 |
53%
upside
| Buy |
9 May ‘25
4 months ago |
|
21
Keros Therapeutics
KROS
$628M
| $15.47 | $25 |
62%
upside
| Buy |
8 May ‘25
4 months ago |
|
22
Denali Therapeutics
DNLI
$2.27B
| $15.50 | $32 |
106%
upside
| Buy |
7 May ‘25
4 months ago |
|
23
BioCryst Pharmaceuticals
BCRX
$1.72B
| $8.19 | $30 |
266%
upside
| Buy |
6 May ‘25
4 months ago |
|
|
DBVT
24
DBV Technologies
DBVT
$238M
| $8.70 | $16 |
84%
upside
| Buy |
5 May ‘25
4 months ago |
|
25
Arvinas
ARVN
$583M
| $7.94 | $24 |
202%
upside
| Buy |
2 May ‘25
4 months ago |
|